These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27235660)

  • 1. [Occurrence of peripheral edema in a switch from buprenorphine alone to the buprenorphine-naloxone combination: About one case].
    Javelot H; Royer T; Javelot T; Muller C; Tebacher M
    Therapie; 2016 Jun; 71(3):341-3. PubMed ID: 27235660
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

  • 3. Sublingual Buprenorphine-Naloxone Exposure and Dental Disease.
    Brothers TD; Lewer D; Bonn M
    JAMA; 2023 Apr; 329(14):1224. PubMed ID: 37039797
    [No Abstract]   [Full Text] [Related]  

  • 4. Integration of buprenorphine for substance-abuse treatment by HIV care providers.
    Friedland G; Vlahov D
    J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1():S1-2. PubMed ID: 21317588
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of the effect of buprenorphine/naloxone with gabapentin or quetiapine.
    Reeves RR; Ladner ME
    Am J Psychiatry; 2014 Jun; 171(6):691. PubMed ID: 24880512
    [No Abstract]   [Full Text] [Related]  

  • 6. The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations.
    Larance B; Dietze P; Ali R; Lintzeris N; White N; Jenkinson R; Degenhardt L
    Drug Alcohol Rev; 2015 Nov; 34(6):603-10. PubMed ID: 25950232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of buprenorphine/naloxone maintenance treatment on sexual dysfunction, sleep and weight in opioid use disorder patients.
    Baykara S; Alban K
    Psychiatry Res; 2019 Feb; 272():450-453. PubMed ID: 30611963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Every Dentist Should Know for Patients Taking Suboxone (Buprenorphine/Naloxone).
    Johnson RE; Rosenberg MB
    J Mass Dent Soc; 2017 Winter; 65(4):16-19. PubMed ID: 29813204
    [No Abstract]   [Full Text] [Related]  

  • 9. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Series of Successful Postoperative Pain Management in Buprenorphine Maintenance Therapy Patients.
    Leighton BL; Crock LW
    Anesth Analg; 2017 Nov; 125(5):1779-1783. PubMed ID: 29049122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic Hand Complications From Intra-Arterial Injection of Sublingual Buprenorphine/Naloxone Among Patients With Opioid Dependency.
    Wilson RM; Elmaraghi S; Rinker BD
    Hand (N Y); 2017 Sep; 12(5):507-511. PubMed ID: 28832211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
    Balhara YP
    J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101
    [No Abstract]   [Full Text] [Related]  

  • 13. A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers.
    Alcaraz S; González-Saiz F; Trujols J; Vergara-Moragues E; Siñol N; Pérez de Los Cobos J;
    Drug Alcohol Depend; 2018 Jun; 187():278-284. PubMed ID: 29702336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foreword to: buprenorphine and buprenorphine/naloxone: a guide for clinicians.
    Fudala PJ; Bridge TP
    Drug Alcohol Depend; 2003 May; 70(2 Suppl):S1-2. PubMed ID: 12738345
    [No Abstract]   [Full Text] [Related]  

  • 15. The Shelby Clinic Medication-Assisted Treatment for Opioid Addiction.
    Penn CL
    J Ark Med Soc; 2016 Aug; 113(2):30-32. PubMed ID: 30047628
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescription drug monitoring programs and buprenorphine maintenance: clinical considerations.
    Hoefer M; Petrakis I
    Am J Addict; 2014; 23(6):616-7. PubMed ID: 25251308
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in psychosocial symptoms of opiate users over six months with buprenorphine/naloxone substitution therapy].
    Petke Z; Csorba J; Meszaros J; Vingender I; Farkas J; Demetrovics Z; Kovacs Z; Menczel Z; Pataki Z; Simor P; Havasi A; Melles K; Marvanykovi F; Racz J
    Neuropsychopharmacol Hung; 2012 Mar; 14(1):7-17. PubMed ID: 22427466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group medication management for buprenorphine/naloxone in opioid-dependent veterans.
    Berger R; Pulido C; Lacro J; Groban S; Robinson S
    J Addict Med; 2014; 8(6):415-20. PubMed ID: 25275875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.